Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Burnout and Resiliency in Canadian Oncology Residents: A Nationwide Resident and Program Director Survey.

Dahn H, McGibbon A, Bowes D.

Pract Radiat Oncol. 2019 Jan;9(1):e118-e125. doi: 10.1016/j.prro.2018.08.001. Epub 2018 Aug 30.

PMID:
30172869
2.

Transition to practice: creation of a transitional rotation for radiation oncology.

Dahn H, Watts K, Best L, Bowes D.

Can Med Educ J. 2018 Jul 27;9(3):e89-e96. eCollection 2018 Jul.

3.

Treatment outcomes and incidence of brain metastases in pulmonary large cell neuroendocrine carcinoma.

Zhao Y, Castonguay M, Wilke D, Xu Z, Plourde M, Mulroy L, MacNeil M, Bowes D.

Curr Probl Cancer. 2019 Feb;43(1):54-65. doi: 10.1016/j.currproblcancer.2018.05.006. Epub 2018 May 24.

PMID:
30107896
4.

Describing a Process for Creating a Patient Visible Quality Educational Display to Increase Patient Engagement in Radiation Oncology Throughout the Canadian Maritimes Provinces.

Moran K, Sinclair L, Freire S, Peters L, Bowes D, Best L, Cherpak A, Darling M, Day T, Trask J, Ilie G.

J Cancer Educ. 2018 Jul 25. doi: 10.1007/s13187-018-1402-0. [Epub ahead of print]

PMID:
30047106
5.

A Phase II trial of 8 weeks of degarelix for prostate volume reduction: Efficacy and hormonal recovery.

Korzeniowski MA, Crook JM, Bowes D, Gaztañaga M, Ots A, Jazwal J, Rose J, Tétreault-Laflamme A, Pilote L, Halperin R, Kim D, Petrik D, Araujo C, Bachand F.

Brachytherapy. 2018 May - Jun;17(3):530-536. doi: 10.1016/j.brachy.2017.12.005. Epub 2018 Feb 2.

PMID:
29398594
6.

Testosterone Suppression with Luteinizing Hormone-Releasing Hormone (LHRH) Agonists in Patients Receiving Radiotherapy for Prostate Cancer.

Wilke D, Patil N, Hollenhorst H, Bowes D, Rutledge R, Ago C.

Pharmacotherapy. 2018 Mar;38(3):327-333. doi: 10.1002/phar.2084. Epub 2018 Feb 7.

PMID:
29337395
7.

Long-term Outcomes and Late Effects of Definitive Chemoradiotherapy in Patients with Cervical Cancer in Nova Scotia.

Royal-Preyra B, Bowes D, Bahl G, Joseph P, Nolan M, Ymeri H, Bentley J, Patil N.

Cureus. 2015 Oct 6;7(10):e343. doi: 10.7759/cureus.343.

8.

IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test.

Bhattacharyya T, Ayandeh A, Falconar AK, Sundar S, El-Safi S, Gripenberg MA, Bowes DE, Thunissen C, Singh OP, Kumar R, Ahmed O, Eisa O, Saad A, Silva Pereira S, Boelaert M, Mertens P, Miles MA.

PLoS Negl Trop Dis. 2014 Oct 23;8(10):e3273. doi: 10.1371/journal.pntd.0003273. eCollection 2014 Oct.

9.

Significantly lower anti-Leishmania IgG responses in Sudanese versus Indian visceral leishmaniasis.

Bhattacharyya T, Bowes DE, El-Safi S, Sundar S, Falconar AK, Singh OP, Kumar R, Ahmed O, Boelaert M, Miles MA.

PLoS Negl Trop Dis. 2014 Feb 20;8(2):e2675. doi: 10.1371/journal.pntd.0002675. eCollection 2014 Feb.

10.

Statement in response to asbestos industry efforts to prevent a ban on asbestos in Pakistan: chrysotile asbestos use is not safe and must be banned.

Aguilar Madrid G, Beaudry M, Bell W, Bowes D, Brophy J, Burdorf A, Carlsten C, Castleman B, Chaturvedi S, Conti ME, Corra L, Corrêa Filho HR, Cranor CF, Cullen E, Dalvie A, Dickson RC, Digon A, Egilman D, Eisner Falvo C, Fischer E, Frank AL, Frank E, Gee D, Giannasi F, Goldstein BD, Greenberg M, Guidotti TL, Harris WA, Hindry M, Houlson A, Hu H, Huff J, Infante PF, Thambyappa J, Juarez Perez CA, Jeebhay MF, Joshi TK, Keith M, Keyserlingk JR, Khatter K, King D, Kodeih N, Kristensen J, Kulsomboon V, Landrigan PJ, Lee CW, Leigh J, Lemen RA, Lippman A, London L, Matzopoulos R, McCulloch J, McDiarmid MA, Mehrdad R, Mirabelli D, Moshammer H, Notebaert É, Nycz Z, Oberta AF, O'Connor J, O'Neill R, Orris P, Ozonoff D, Paek D, Rickard C, Rodriguez EJ, Sass J, Sentes KE, Simpson IM, Soffritti M, Soskolne CL, Sparling SP, Spiegel J, Takahashi K, Takaro TK, Terracini B, Thébaud-Mony A, Trosic I, Turcotte F, Vakil C, Van Der Walt A, Waterman YR, Watterson A, Wegman DH, Welch LS, Weiss SH, Winston R, Yassi A.

Arch Environ Occup Health. 2013;68(4):243-9. doi: 10.1080/19338244.2013.780807. No abstract available.

PMID:
23697697
11.

A randomized trial comparing seed displacement of coated seeds to regular loose seeds at 30 days postimplant.

Bowes D, Gaztañaga M, Araujo C, Kim D, Parker B, Batchelar D, Milette MP, Rajapakshe R, Petrik D, Halperin R, Crook JM.

Brachytherapy. 2013 Jul-Aug;12(4):362-7. doi: 10.1016/j.brachy.2013.01.166. Epub 2013 Mar 9.

PMID:
23477886
12.

Ultrasound-CT fusion compared with MR-CT fusion for postimplant dosimetry in permanent prostate brachytherapy.

Bowes D, Crook JM, Araujo C, Batchelar D.

Brachytherapy. 2013 Jan-Feb;12(1):38-43. doi: 10.1016/j.brachy.2012.03.007. Epub 2012 Jun 21.

13.

Results of a surgically derived nomogram to predict Gleason score upgrading applied to a cohort of patients with "favorable-risk" prostate cancer treated with permanent seed brachytherapy.

Bowes D, Crook JM, Wallace K, Evans A, Toi A, Finelli A, Jewett MA, Fleshner N, Catton C.

Urology. 2012 Sep;80(3):649-55. doi: 10.1016/j.urology.2012.03.051. Epub 2012 Jun 13.

PMID:
22698474
14.

Defining a magnetic resonance scan sequence for permanent seed prostate brachytherapy postimplant assessment.

Bowes D, Crook JM, Rajapakshe R, Araujo C, Parker B.

Brachytherapy. 2013 Jan-Feb;12(1):25-9. doi: 10.1016/j.brachy.2012.03.001. Epub 2012 Apr 17.

15.

In regard to "Dose escalation in the radiation therapy of prostate cancer" (Int J Radiat Oncol Biol Phys 2011;80:1289-1291).

Bowes D, Crook J.

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1317-8. doi: 10.1016/j.ijrobp.2011.11.010. No abstract available.

PMID:
22385710
16.

A critical analysis of the long-term impact of brachytherapy for prostate cancer: a review of the recent literature.

Bowes D, Crook J.

Curr Opin Urol. 2011 May;21(3):219-24. doi: 10.1097/MOU.0b013e3283449d52. Review.

PMID:
21311335
17.

Process evaluation of a school-based intervention to increase physical activity and reduce bullying.

Bowes D, Marquis M, Young W, Holowaty P, Isaac W.

Health Promot Pract. 2009 Jul;10(3):394-401. doi: 10.1177/1524839907307886. Epub 2008 Mar 18.

PMID:
18349146
18.

A new inter-professional course preparing learners for life in rural communities.

Medves J, Paterson M, Chapman CY, Young JH, Tata E, Bowes D, Hobbs N, McAndrews B, O'Riordan A.

Rural Remote Health. 2008 Jan-Mar;8(1):836. Epub 2008 Feb 21.

19.

Thinking about errors.

Bowes D.

Can Fam Physician. 2007 Apr;53(4):626. No abstract available.

20.

Preparing professionals from a wide range of disciplines for life and work in rural and small communities.

Medves JM, Paterson M, Young TR, McAndrews B, Bowes D, Smith TR, Hobbs N, Seaton F.

Aust J Rural Health. 2006 Oct;14(5):225-6.

PMID:
17032300
21.

A life in the country.

Bowes D, Hobbs N, McAndrews B, Medves J, Paterson M, Smith E, Young JH.

CMAJ. 2005 Jul 19;173(2):127-8. No abstract available.

22.

Pharmacists helping physicians.

Bowes D.

CMAJ. 2003 Jan 21;168(2):151. No abstract available.

23.

Women living with ovarian cancer: dealing with an early death.

Bowes DE, Tamlyn D, Butler LJ.

Health Care Women Int. 2002 Feb;23(2):135-48.

PMID:
11868961
24.

Applying the Sports Medicine Australia pre-exercise screening procedures: who will be excluded?

Norton K, Olds T, Bowes D, Van Ly S, Gore C.

J Sci Med Sport. 1998 Jan;1(1):38-51.

PMID:
9732120
25.

Major and trace element compositions of the UICC standard asbestos samples.

Bowes DR, Farrow CM.

Am J Ind Med. 1997 Dec;32(6):592-4. Erratum in: Am J Ind Med 1998 Apr;33(4):425. Am J Ind Med 1998 Feb;33(2):192.

PMID:
9358914
26.

The palliative care team and the dental hygienist.

Bowes D, Murray K.

Probe. 1997 Jul-Aug;31(4):127, 136. No abstract available.

PMID:
9611437
27.
28.

An algorithm for the surgical management of chronic abdominal aortic occlusion and occluded aortofemoral grafts.

Bowes DE, Youkey JR, Franklin DP, Benoit CH, Pharr WF.

J Cardiovasc Surg (Torino). 1992 Nov-Dec;33(6):650-9.

PMID:
1287001
29.

Brutus is making rounds.

Rosenkoetter MM, Bowes D.

Geriatr Nurs. 1991 Nov-Dec;12(6):277-8.

PMID:
1666879
30.

Long term follow-up of descending thoracic aorto-iliac/femoral bypass.

Bowes DE, Youkey JR, Pharr WP, Goldstein AM, Benoit CH.

J Cardiovasc Surg (Torino). 1990 Jul-Aug;31(4):430-7.

PMID:
2211794
31.

Descending thoracic aortobifemoral bypass for occluded abdominal aorta: retroperitoneal route without an abdominal incision.

Bowes DE, Keagy BA, Benoit CH, Pharr WF.

J Cardiovasc Surg (Torino). 1985 Jan-Feb;26(1):41-5.

PMID:
3968159
32.

The doctor as patient: an encounter with Guillain-Bárré syndrome.

Bowes D.

Can Med Assoc J. 1984 Dec 1;131(11):1343-8.

33.

A review of morbidity and mortality in elderly patients undergoing pulmonary resection.

Keagy BA, Pharr WF, Bowes DE, Wilcox BR.

Am Surg. 1984 Apr;50(4):213-6.

PMID:
6712015
34.

Tibial condylar fractures. Evaluation of treatment and outcome.

Bowes DN, Hohl M.

Clin Orthop Relat Res. 1982 Nov-Dec;(171):104-8.

PMID:
7140056
35.

Objective criteria for the interpretation of carotid artery spectral analysis patterns.

Keagy BA, Pharr WF, Thomas D, Bowes DE.

Angiology. 1982 Apr;33(4):213-20.

PMID:
7073015
36.

A quantitative method for the evaluation of spectral analysis patterns in carotid artery stenosis.

Keagy BA, Pharr WF, Thomas D, Bowes DE.

Ultrasound Med Biol. 1982;8(6):625-30.

PMID:
7164180
37.
38.

Comparison of reactive hyperemia and treadmill tests in the evaluation of peripheral vascular disease.

Keagy BA, Pharr WF, Thomas D, Bowes DE.

Am J Surg. 1981 Jul;142(1):158-61.

PMID:
7258508
39.
40.

Unusual presentations of abdominal aortic aneurysms.

Keagy BA, Pharr WF, Bowes DE.

J Cardiovasc Surg (Torino). 1981 Jan-Feb;22(1):41-6.

PMID:
7217187
41.
42.

Electron microscopy of lysosomal fractions from guinea pig heart.

Welman E, Bowes D, Peters TJ.

J Mol Cell Cardiol. 1978 Jun;10(6):527-33. No abstract available.

PMID:
691066
43.

Postnatal growth of the mouse lung.

Amy RW, Bowes D, Burri PH, Haines J, Thurlbeck WM.

J Anat. 1977 Sep;124(Pt 1):131-51. No abstract available.

44.
45.

Consumer talcums and powders: mineral and chemical characterization.

Rohl AN, Langer AM, Selikoff IJ, Tordini A, Klimentidis R, Bowes DR, Skinner DL.

J Toxicol Environ Health. 1976 Nov;2(2):255-84.

PMID:
1011287
46.

Quantification and identification of particle movement in epidermis after thermal injury.

Bach CS, Bowes D, Bullock GR, Lewis GP.

Histochem J. 1976 Jul;8(4):331-9.

PMID:
955969
47.

A simple vacuum cassette for microradiography.

Bowes DN, Dunn EJ.

Stain Technol. 1975 Sep;50(5):355-7.

PMID:
1209662
48.

Letter: Microradiography of bone, a new use for the versatile Faxitron.

Dunn EJ, Bowes DW, Rothert SW, Greer RB 3rd.

Arch Pathol. 1975 Jan;99(1):62. No abstract available.

PMID:
1111498
49.
50.

Microradiography of undecalcified bone: a simplified, relatively inexpensive technique.

Dunn EJ, Bowes DN, Rothert SW, Greer RB 3rd.

Johns Hopkins Med J. 1974 Aug;135(2):106-13. No abstract available.

PMID:
4604775

Supplemental Content

Support Center